HR 4619 · 116th Congress · Health

Pharmaceutical REPAI Act

Introduced 2019-10-08· Sponsored by Rep. Schakowsky, Janice D. [D-IL-9]· House

Bill Progress

✓
Introduced
2
Committee
3
House Vote
4
Senate
5
Enacted
Latest: Referred to the Subcommittee on Health.(2019-10-09)

Plain Language Summary

[AI summary unavailable — showing source text] Pharmaceutical Rebates for Excessive Pricing Above Inflation Act or the Pharmaceutical REPAI Act This bill requires drug manufacturers, subject to civil penalties, to issue rebates to the Centers for Medicare & Medicaid Services for covered drugs under the Medicare prescription drug benefit that cost $100 or more and for which the average manufacturer price increases faster than inflation.…

Summarized by Claude AI · Non-partisan · For informational purposes only

Cosponsors (2)

2 Democrats
Rep. Higgins, Brian [D-NY-26]NY
Rep. Wild, Susan [D-PA-7]PA